Assessment of intraoperative bleeding in reverse shoulder arthroplasty - with or without a stem.


Journal

Orthopaedics & traumatology, surgery & research : OTSR
ISSN: 1877-0568
Titre abrégé: Orthop Traumatol Surg Res
Pays: France
ID NLM: 101494830

Informations de publication

Date de publication:
05 2022
Historique:
received: 06 06 2021
revised: 18 11 2021
accepted: 26 11 2021
pubmed: 15 2 2022
medline: 20 5 2022
entrez: 14 2 2022
Statut: ppublish

Résumé

The functional results of stemless reverse shoulder prostheses are similar to those with stems. However, the operative time and the bleeding appear less significant because of the absence of humeral reaming. To date, the data amongst the literature regarding this subject is limited. Thus, we report a retrospective evaluation on these 2 types of prostheses by assessing their respective intraoperative blood loss. Reverse shoulder arthroplasty without a stem leads to less blood loss, compared to arthroplasty with a stem. Twenty-three patients underwent an operation for a stemless prosthesis, while 37 patients had a prosthesis with a stem. The hemoglobin was measured preoperatively, as well as postoperatively. Drainage of the operative site was maintained for two to three days. In the stem group, the preoperative hemoglobin was 14g/dL (11.7-16.6), while it was 13.1g/dL (11-15.8) in the stemless group. The intraoperative bleeding reached 223cm There is no significant difference concerning the blood loss between reverse shoulder replacements with and without stems. III Retrospective case control study.

Identifiants

pubmed: 35158104
pii: S1877-0568(22)00050-0
doi: 10.1016/j.otsr.2022.103245
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103245

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Auteurs

Fiona Sakek (F)

CHU Besançon, 3, boulevard Alexandre-Fleming, 25000 Besançon, France. Electronic address: fiona2sakek@gmail.com.

Harrison Haight (H)

CHU Besançon, 3, boulevard Alexandre-Fleming, 25000 Besançon, France.

Pierre Tuphé (P)

CHU Besançon, 3, boulevard Alexandre-Fleming, 25000 Besançon, France.

Inès Regas (I)

CHU Besançon, 3, boulevard Alexandre-Fleming, 25000 Besançon, France.

Antoine Adam (A)

CHU Besançon, 3, boulevard Alexandre-Fleming, 25000 Besançon, France.

Séverin Rochet (S)

CHU Besançon, 3, boulevard Alexandre-Fleming, 25000 Besançon, France.

Tristan Lascar (T)

Centre Hospitalier Princesse Grace, Monaco, Monaco.

Laurent Obert (L)

CHU Besançon, 3, boulevard Alexandre-Fleming, 25000 Besançon, France.

François Loisel (F)

CHU Besançon, 3, boulevard Alexandre-Fleming, 25000 Besançon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH